Page last updated: 2024-10-31

nefopam and Serotonin Syndrome

nefopam has been researched along with Serotonin Syndrome in 1 studies

Nefopam: Non-narcotic analgesic chemically similar to ORPHENADRINE. Its mechanism of action is unclear. It is used for the relief of acute and chronic pain. (From Martindale, The Extra Pharmacopoeia, 30th ed, p26)
nefopam : A racemate comprising equal amounts of (R)- and (S)-nefopam. The hydrochloride is a centrally acting non-opiate analgesic commonly used for the treatment of moderate to severe pain.
5-methyl-1-phenyl-3,4,5,6-tetrahydro-1H-2,5-benzoxazocine : A member of the class of benzoxazocines that is 3,4,5,6-tetrahydro-1H-2,5-benzoxazocine substituted by phenyl and methyl groups at positions 1 and 5 respectively.

Serotonin Syndrome: An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Trungu, J1
Laarbaui, F1
Dechamps, M1
Hantson, P1

Other Studies

1 other study available for nefopam and Serotonin Syndrome

ArticleYear
Rapidly fatal neurological and cardiocirculatory failure in a patient recently treated with nefopam.
    Minerva anestesiologica, 2019, Volume: 85, Issue:5

    Topics: Aged; Analgesics, Non-Narcotic; Fatal Outcome; Female; Humans; Nefopam; Nervous System Diseases; Ser

2019